FindTrial
Sign In

mRNA COVID-19 vaccine

BIOLOGICAL5 trials

Sponsors

Novartis Pharmaceuticals, City of Hope Medical Center, Duke University, Ana Belen Rivas Paterna

Conditions

Adverse Event Following ImmunizationBirth OutcomesCOVID-19 InfectionCOVID-19 Vaccine Adverse ReactionChronic Lymphocytic LeukemiaFeverFever After VaccinationRelapsing Multiple Sclerosis (RMS)

Phase 2

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia
CompletedNCT05672355
City of Hope Medical CenterChronic Lymphocytic Leukemia, COVID-19 Infection
Start: 2023-08-01End: 2026-07-07Updated: 2026-09-09

Phase 4

A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab
TerminatedNCT04878211
Novartis PharmaceuticalsRelapsing Multiple Sclerosis (RMS)
Start: 2021-06-10End: 2023-04-14Updated: 2025-05-16
Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children
CompletedNCT06038617
Duke UniversityFever, Fever After Vaccination, Seizures Fever
Start: 2023-10-30End: 2025-07-25Updated: 2026-05-13
Simultaneous mRNA COVID-19 and IIV Vaccination in Pregnancy Study
CompletedNCT06503900
Duke UniversityAdverse Event Following Immunization, Birth Outcomes, Safety
Start: 2024-09-12End: 2025-11-19Updated: 2026-01-15

Unknown Phase

Safety Study About the mRNA Vaccines Against COVID-19 in Children (PEDIVACOV-HCSC)
CompletedNCT06646744
Ana Belen Rivas PaternaCOVID-19 Vaccine Adverse Reaction
Start: 2022-03-08End: 2023-03-03Updated: 2024-10-17